DMRA
DMRA
KYG2646Y1044
Damora Therapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
1.3B EUR
1.61B EUR
1.56B EUR
36.75M EUR
Enterprise Value
858.76M EUR
1.07B EUR
1.03B EUR
-220.8M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-9.7x
--
--
--
Price to Sales
--
--
--
--
Price to Book
3.37x
3.11x
3.05x
0.15x
EV/Revenue
--
--
--
--
EV/EBITDA
-8.92x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-1.23%
-2.77%
-1.59%
-11.66%
ende